ArticleFrontiers in veterinary science2026
Differences among canine serum, plasma and urine metabolite profiles from samples that were collected at the same time.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Biospecimen choice can substantially influence metabolite measurements, yet matched comparisons of serum, EDTA plasma, lithium-heparin plasma, and urine remain limited in canine targeted metabolomics. Objectives: To evaluate cross-matrix comparability of targeted small polar metabolite profiles in dogs and to assess how different biospecimens capture diet- and health-associated variation. Animals: Client-owned dogs from a previously reported feeding trial. Methods: Targeted ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was performed on matched biospecimens from a baseline blood-matrix cohort (serum, EDTA plasma, lithium-heparin plasma) and an end-of-trial serum-urine cohort. Metabolites with >20% missing values within a matrix and samples with >20% missing metabolite values within a biofluid were excluded. Cross-matrix agreement was assessed using Pearson correlation and mean paired log Results: After filtering, 88 metabolites remained for serum, 85 for EDTA plasma, and 88 for lithium-heparin plasma in the blood-matrix cohort. Globally, EDTA plasma separated clearly from both serum and lithium-heparin plasma, whereas serum and lithium-heparin plasma overlapped substantially. At the metabolite level, 10/84 (11.9%) serum-EDTA plasma, 16/88 (18.2%) serum-lithium-heparin plasma, 20/84 (23.8%) lithium-heparin plasma-EDTA plasma, and 4/75 (5.3%) serum-urine comparisons were comparable to varying degrees. Serum showed the clearest diet-associated separation at baseline (PERMANOVA pseudo- Conclusions and Clinical Importance: Biospecimen choice materially affects targeted metabolite profiling in dogs. Serum and lithium-heparin plasma were globally more similar to each other than either was to EDTA plasma, whereas urine was a distinct complementary matrix rather than a blood surrogate. Serum was the most robust matrix for detecting diet-associated variation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.